4 results about "Blood calcium" patented technology

The present application relates to a kind of ammonium chloride calcium stick, belong to the technical field of feed.The ammonium chloride calcium stick includes the following components: calcium chloride, calcium sulfate, ammonium chloride, vitamin B6, modified cysteine, syringaldehyde, vitamin D3, sodium tripolyphosphate and solvent.Sodium tripolyphosphate maintains the stability of vitamin D3 and vitamin B6, wherein vitamin B6 inhibits prolactin synthesis, vitamin D3 promotes calcium absorption, prevents low blood calcium and excessive mammary secretion.The present application modifies cysteine by eugenol, increases its stability and dispersibility, and forms electrostatic interaction with sodium tripolyphosphate, forms a stable crosslinking network structure, increases the binding force between the coating layer and the raw material, prevents the loss of effective dry milk ingredients, and achieves better dry milk effect.

A liquid embolic composition of natural polymers, water, and angiographic contrast agents improves neurovascular interventions, making them more reliable, safe, and affordable. The embolic material is made of a single component activated by blood calcium ion, which triggers coagulation, and that offers superior mechanical stability and does not cause fragmentation in the target vessel. The material retains superior long-term mechanical durability after deployment and provides sufficient visualization under fluoroscopy with iodine-based angiographic contrast compounds or other radiopaque compositions. Described herein are aqueous solutions that enable a high concentration gellan gum (greater than 0.5 wt %) to retain sol state even at the range of body temperature (30-40° C.). This discovery means that it is possible to increase the concentration of gellan gum without losing its inject-ability, yet significantly improve its mechanical stability after delivery.

The invention provides an rTGA technology fish oil composite capsule and application thereof to cardiovascular and bone health. According to the capsule, a high-purity fish oil substrate with the total content of EPA and DHA being larger than or equal to 75% is prepared through an rTGA technology, the high-purity fish oil substrate is compounded with vitamin D3 and a composite antioxidant in a specific proportion, and then packaging is conducted through a double-layer microencapsulation embedding technology (an inner layer complex coacervation wall material and an outer layer enteric coating). The invention solves the problems of poor compounding stability of high-purity Omega-3 and vitamin D3 and lack of synergistic effect verification. The obtained product can significantly improve the blood fat level (reduce TG and TC) and bone health indexes (increase blood calcium and improve bone mineral density) at the same time, and an innovative scheme is provided for developing dietary supplements with clear cardiovascular and bone dual health functions.

The invention relates to a clinical diagnosis model for early diagnosis of fever with thrombocytopenia syndrome (SFTS) complicated by acute pancreatitis (AP) and a construction method thereof. The model is constructed through Logistic regression analysis and LASSO regression analysis on the basis of indexes such as virus load (DBV RNA), thrombin time (TT), amylase (AMY) and blood calcium (Ca). The model shows good distinction degree and calibration degree in a training queue and a verification queue, can effectively predict the risk of concurrent AP of the SFTS patient, and has relatively high clinical practicability and prediction accuracy.